A recent analysis of global chemokine expression in SSc described high CCL19 and CXCL13 levels present in the skin of patients with diffuse SSc, whereas CCL18 levels were increased in the skin of patients with either limited or diffuse SSc [203]. This evidence concerns the gene CCL18 and systemic sclerosis.